MS Briefs

Criterion Based on the Central Vein Sign Distinguishes Between MS and Mimics

Sinnecker T et al. AAN 2019, Abstract S6.002.


 

Key clinical point : Applying a criterion of three lesions with the central vein sign distinguishes between multiple sclerosis and its mimics.

Major finding : The criterion has a sensitivity and specificity of 61.9% and 89.0%, respectively.

Study details : A multicenter study of 606 participants with clinically isolated syndrome, multiple sclerosis, and multiple sclerosis mimics.

Disclosures: Dr. Sinnecker reported receiving personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Actelion.

Citation: Sinnecker T et al. AAN 2019, Abstract S6.002 .

Recommended Reading

Researchers examine vitamin D, skin pigmentation, and outcomes of pediatric MS
ICYMI Multiple Sclerosis
The art of selecting an MS therapy
ICYMI Multiple Sclerosis
Ibudilast’s efficacy differs in primary and secondary progressive MS
ICYMI Multiple Sclerosis
BTK inhibitor reduces MS enhancing lesions
ICYMI Multiple Sclerosis
Changes in brain networks may predict MS worsening
ICYMI Multiple Sclerosis
Interview with Stephen Krieger, MD, on the topographical model of multiple sclerosis
ICYMI Multiple Sclerosis
Sugary drink intake may be associated with MS severity
ICYMI Multiple Sclerosis
Fingolimod reduced disease activity more than glatiramer acetate in RRMS: ASSESS study results
ICYMI Multiple Sclerosis
Evobrutinib demonstrates efficacy, safety in relapsing MS
ICYMI Multiple Sclerosis
Multiple Sclerosis May Not Flare Up After Pregnancy
ICYMI Multiple Sclerosis